Cargando…
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
INTRODUCTION: We have shown that the radio sensitizer DCQ enhances sensitivity of HCT116 human colon cancer cells to hypoxia. However, it is not known whether the p53 or p21 genes influence cellular response to DCQ. In this study, we used HCT116 that are either wildtype for p53 and p21, null for p53...
Autores principales: | El-Khatib, Mona, Geara, Fady, Haddadin, Makhluf J, Gali-Muhtasib, Hala |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993715/ https://www.ncbi.nlm.nih.gov/pubmed/21078189 http://dx.doi.org/10.1186/1748-717X-5-107 |
Ejemplares similares
-
The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway
por: Ghattass, Khaled, et al.
Publicado: (2014) -
Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells
por: Itani, Wafica, et al.
Publicado: (2007) -
The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells
por: Haykal, Joelle, et al.
Publicado: (2009) -
Novel 2-(5-Imino-5H-isoquinolones[3,4-b]quinoxalin-7-ylmethyl)-benzonitrile
(DIQ3) and Other Related Derivatives Targeting Colon
Cancer Cells: Syntheses and in Vitro Models
por: Monzer, Alissar, et al.
Publicado: (2019) -
The Role of the Cyclin Dependent Kinase Inhibitor p21(cip1/waf1) in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
por: Al Bitar, Samar, et al.
Publicado: (2019)